Publications

5674 Results

A phase II trial of recombinant tumor necrosis factor in patients with metastatic colorectal adenocarcinoma. A Southwest Oncology Group study.

Authors
RP Whitehead;T Fleming;JS Macdonald;PJ Goodman;J Neefe;TJ Braun;LJ Swinnen;EM Hersh
Journal / Conference
JBRM 9:588-591
Year
1990
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8743

Determinants of improved outcome in small cell lung cancer: An analysis of 2,580-patient Southwest Oncology Group data base.

Authors
KS Albain;JJ Crowley;M LeBlanc;RB Livingston
Journal / Conference
JCO 8(9):1563-1574
Year
1990
Research Committee(s)
Lung
Study Number(s)
SWOG-7628, SWOG-7828, SWOG-7924, SWOG-8122, SWOG-8232, SWOG-8269, SWOG-8573, SWOG-8606

Immunobiologic factors predictive of clinical outcome in diffuse large-cell lymphoma.

Authors
DJ Slymen;TP Miller;SM Lippman;CM Spier;DP Kerrigan;JA Rybski;CS Rangel;LC Richter;TM Grogan
Journal / Conference
JCO 8:986-993
Year
1990
Research Committee(s)
Lymphoma

Clinical applications of cellular DNA content parameters determined by flow cytometry in squamous cell cancers of the head and neck.

Authors
JF Ensley;Z Maciorowski;H Pietraszkiewicz;F deBraud;W Sakr;J Kish;M Al-Sarraf;E Tapazoglou
Journal / Conference
Adjuvant Therapy of Cancer IV:101-108
Year
1990
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8855

Methodology and clinical applications of cellular DNA content parameters determined by flow cytometry in squamous cell cancers of the head and neck.

Authors
JF Ensley;Z Maciorowski;H Pietraszkiewicz;F deBraud;W Sakr
Journal / Conference
Carcinoma of the Head and Neck Evaluation of Management :225-242
Year
1990
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8855

The molecular biology of acute myeloid leukemia. Proto-oncogene expression and function in normal and neoplastic myeloid cells.

Authors
CL Willman;MH Whittaker
Journal / Conference
Clinics in Laboratory Medicine 10(4):769-796
Year
1990
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600, SWOG-8750

Southwest Oncology Group.

Authors
C Coltman, Jr
Journal / Conference
Cancer Suppl 65(supp 1):2385-2387
Year
1990

Age < 35 years is an adverse prognostic feature in premenopausal node-positive breast cancer patients (PTS) in Southwest Oncology Group studies.

Authors
K Albain;S Green;S Rivkin;K Osborne
Journal / Conference
ASCO 9:35(#132)
Year
1990
Research Committee(s)
Breast
Study Number(s)
SWOG-7436, SWOG-7827

Adjuvant combination chemotherapy (CMFV P) vs tamoxifen (TAM) vs CMFVP+TAM for postmenopausal women with ER+ operable breast cancer and positive axillary lymph nodes: An intergroup study.

Authors
S Rivkin;S Green;B Metch;A Cruz;R McDivitt;W Knight;J Glick;CK Osborne
Journal / Conference
ASCO 9:24(#87)
Year
1990
Research Committee(s)
Breast
Study Number(s)
SWOG-7827

Effect of colony-forming unit dose of connaught BCG on outcome to immunotherapy in superficial bladder cancer: A Southwest Oncology Group study.

Authors
B Blumenstein;D Lamm;MAS Jewett;G Humphries;L Boux;J Montie;P Scardino;H Grossman;D Crawford;JA Smith;T Stanisic
Journal / Conference
Journal of Urology 143(4):340A
Year
1990
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8216/38